Regulation of cell proliferation by the antizyme inhibitor: Evidence for an antizyme-independent mechanism

Sonia W. Kim, Ursula Mangold, Carol Waghorne, Arian Mobascher, Lisa Shantz, Jacqueline Banyard, Bruce R. Zetter

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

The antizyme inhibitor was discovered as a protein that binds to the regulatory protein antizyme and inhibits the ability of antizyme to interact with the enzyme ornithine decarboxylase (ODC). Blocking antizyme activity subsequently leads to increased intracellular levels of ODC and increased ODC enzymatic activity. We now report that antizyme inhibitor is a positive modulator of cell growth. Overexpression of antizyme inhibitor in NIH-3T3 mouse fibroblasts or in AT2.1 Dunning rat prostate carcinoma cells resulted in an increased rate of cell proliferation and an increase in saturation density of the cultured cells. This was accompanied by an increase in intracellular levels of the polyamine putrescine. In AT2.1 cells, antizyme inhibitor overexpression also increased the ability of the cells to form foci when grown under anchorage-independent conditions. In order to determine the role of antizyme on antizyme inhibitor activity we created an antizyme inhibitor mutant, AZIΔ117-140, which lacks the putative antizyme-binding domain. We show that this mutant fails to bind to antizyme, but remains capable of inducing increased rates of cell proliferation, suggesting that antizyme inhibitor has antizyme-independent functions. Silencing antizyme inhibitor expression leads to diminished levels of cyclin D1 and to reduced cell proliferation. Antizyme inhibitor is capable of preventing cyclin D1 degradation, and this effect is at least partially independent of antizyme. We show that wild-type antizyme inhibitor and the AZIΔ117-140 mutant are capable of direct interaction with cyclin D1 suggesting a potential mechanism for the antizyme-independent effects. Together, our data suggest a novel function for antizyme inhibitor in cellular growth control.

Original languageEnglish (US)
Pages (from-to)2583-2591
Number of pages9
JournalJournal of Cell Science
Volume119
Issue number12
DOIs
StatePublished - Jun 15 2006

Fingerprint

Ornithine Decarboxylase
Cyclin D1
Cell Proliferation
Putrescine
Polyamines
Growth
Prostate
Cultured Cells
Proteins
Fibroblasts
Carcinoma
Enzymes

All Science Journal Classification (ASJC) codes

  • Cell Biology

Cite this

Kim, Sonia W. ; Mangold, Ursula ; Waghorne, Carol ; Mobascher, Arian ; Shantz, Lisa ; Banyard, Jacqueline ; Zetter, Bruce R. / Regulation of cell proliferation by the antizyme inhibitor : Evidence for an antizyme-independent mechanism. In: Journal of Cell Science. 2006 ; Vol. 119, No. 12. pp. 2583-2591.
@article{9874f750bd764e30993b82241a171acc,
title = "Regulation of cell proliferation by the antizyme inhibitor: Evidence for an antizyme-independent mechanism",
abstract = "The antizyme inhibitor was discovered as a protein that binds to the regulatory protein antizyme and inhibits the ability of antizyme to interact with the enzyme ornithine decarboxylase (ODC). Blocking antizyme activity subsequently leads to increased intracellular levels of ODC and increased ODC enzymatic activity. We now report that antizyme inhibitor is a positive modulator of cell growth. Overexpression of antizyme inhibitor in NIH-3T3 mouse fibroblasts or in AT2.1 Dunning rat prostate carcinoma cells resulted in an increased rate of cell proliferation and an increase in saturation density of the cultured cells. This was accompanied by an increase in intracellular levels of the polyamine putrescine. In AT2.1 cells, antizyme inhibitor overexpression also increased the ability of the cells to form foci when grown under anchorage-independent conditions. In order to determine the role of antizyme on antizyme inhibitor activity we created an antizyme inhibitor mutant, AZIΔ117-140, which lacks the putative antizyme-binding domain. We show that this mutant fails to bind to antizyme, but remains capable of inducing increased rates of cell proliferation, suggesting that antizyme inhibitor has antizyme-independent functions. Silencing antizyme inhibitor expression leads to diminished levels of cyclin D1 and to reduced cell proliferation. Antizyme inhibitor is capable of preventing cyclin D1 degradation, and this effect is at least partially independent of antizyme. We show that wild-type antizyme inhibitor and the AZIΔ117-140 mutant are capable of direct interaction with cyclin D1 suggesting a potential mechanism for the antizyme-independent effects. Together, our data suggest a novel function for antizyme inhibitor in cellular growth control.",
author = "Kim, {Sonia W.} and Ursula Mangold and Carol Waghorne and Arian Mobascher and Lisa Shantz and Jacqueline Banyard and Zetter, {Bruce R.}",
year = "2006",
month = "6",
day = "15",
doi = "10.1242/jcs.02966",
language = "English (US)",
volume = "119",
pages = "2583--2591",
journal = "Journal of Cell Science",
issn = "0021-9533",
publisher = "Company of Biologists Ltd",
number = "12",

}

Kim, SW, Mangold, U, Waghorne, C, Mobascher, A, Shantz, L, Banyard, J & Zetter, BR 2006, 'Regulation of cell proliferation by the antizyme inhibitor: Evidence for an antizyme-independent mechanism', Journal of Cell Science, vol. 119, no. 12, pp. 2583-2591. https://doi.org/10.1242/jcs.02966

Regulation of cell proliferation by the antizyme inhibitor : Evidence for an antizyme-independent mechanism. / Kim, Sonia W.; Mangold, Ursula; Waghorne, Carol; Mobascher, Arian; Shantz, Lisa; Banyard, Jacqueline; Zetter, Bruce R.

In: Journal of Cell Science, Vol. 119, No. 12, 15.06.2006, p. 2583-2591.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Regulation of cell proliferation by the antizyme inhibitor

T2 - Evidence for an antizyme-independent mechanism

AU - Kim, Sonia W.

AU - Mangold, Ursula

AU - Waghorne, Carol

AU - Mobascher, Arian

AU - Shantz, Lisa

AU - Banyard, Jacqueline

AU - Zetter, Bruce R.

PY - 2006/6/15

Y1 - 2006/6/15

N2 - The antizyme inhibitor was discovered as a protein that binds to the regulatory protein antizyme and inhibits the ability of antizyme to interact with the enzyme ornithine decarboxylase (ODC). Blocking antizyme activity subsequently leads to increased intracellular levels of ODC and increased ODC enzymatic activity. We now report that antizyme inhibitor is a positive modulator of cell growth. Overexpression of antizyme inhibitor in NIH-3T3 mouse fibroblasts or in AT2.1 Dunning rat prostate carcinoma cells resulted in an increased rate of cell proliferation and an increase in saturation density of the cultured cells. This was accompanied by an increase in intracellular levels of the polyamine putrescine. In AT2.1 cells, antizyme inhibitor overexpression also increased the ability of the cells to form foci when grown under anchorage-independent conditions. In order to determine the role of antizyme on antizyme inhibitor activity we created an antizyme inhibitor mutant, AZIΔ117-140, which lacks the putative antizyme-binding domain. We show that this mutant fails to bind to antizyme, but remains capable of inducing increased rates of cell proliferation, suggesting that antizyme inhibitor has antizyme-independent functions. Silencing antizyme inhibitor expression leads to diminished levels of cyclin D1 and to reduced cell proliferation. Antizyme inhibitor is capable of preventing cyclin D1 degradation, and this effect is at least partially independent of antizyme. We show that wild-type antizyme inhibitor and the AZIΔ117-140 mutant are capable of direct interaction with cyclin D1 suggesting a potential mechanism for the antizyme-independent effects. Together, our data suggest a novel function for antizyme inhibitor in cellular growth control.

AB - The antizyme inhibitor was discovered as a protein that binds to the regulatory protein antizyme and inhibits the ability of antizyme to interact with the enzyme ornithine decarboxylase (ODC). Blocking antizyme activity subsequently leads to increased intracellular levels of ODC and increased ODC enzymatic activity. We now report that antizyme inhibitor is a positive modulator of cell growth. Overexpression of antizyme inhibitor in NIH-3T3 mouse fibroblasts or in AT2.1 Dunning rat prostate carcinoma cells resulted in an increased rate of cell proliferation and an increase in saturation density of the cultured cells. This was accompanied by an increase in intracellular levels of the polyamine putrescine. In AT2.1 cells, antizyme inhibitor overexpression also increased the ability of the cells to form foci when grown under anchorage-independent conditions. In order to determine the role of antizyme on antizyme inhibitor activity we created an antizyme inhibitor mutant, AZIΔ117-140, which lacks the putative antizyme-binding domain. We show that this mutant fails to bind to antizyme, but remains capable of inducing increased rates of cell proliferation, suggesting that antizyme inhibitor has antizyme-independent functions. Silencing antizyme inhibitor expression leads to diminished levels of cyclin D1 and to reduced cell proliferation. Antizyme inhibitor is capable of preventing cyclin D1 degradation, and this effect is at least partially independent of antizyme. We show that wild-type antizyme inhibitor and the AZIΔ117-140 mutant are capable of direct interaction with cyclin D1 suggesting a potential mechanism for the antizyme-independent effects. Together, our data suggest a novel function for antizyme inhibitor in cellular growth control.

UR - http://www.scopus.com/inward/record.url?scp=33746102203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746102203&partnerID=8YFLogxK

U2 - 10.1242/jcs.02966

DO - 10.1242/jcs.02966

M3 - Article

C2 - 16735445

AN - SCOPUS:33746102203

VL - 119

SP - 2583

EP - 2591

JO - Journal of Cell Science

JF - Journal of Cell Science

SN - 0021-9533

IS - 12

ER -